Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, and carbonic anhydrase inhibition activity of benzenesulfonamide-linked novel pyrazoline derivatives
Alaa A.‐M. Abdel‐Aziz, Adel S. El‐Azab, Silvia Bua, et al.
Bioorganic Chemistry (2019) Vol. 87, pp. 425-431
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors
Shubham Kumar, Sandeep Rulhania, Shalini Jaswal, et al.
European Journal of Medicinal Chemistry (2020) Vol. 209, pp. 112923-112923
Closed Access | Times Cited: 114
Recent advancements in the development of bioactive pyrazoline derivatives
Bhupender Nehra, Sandeep Rulhania, Shalini Jaswal, et al.
European Journal of Medicinal Chemistry (2020) Vol. 205, pp. 112666-112666
Closed Access | Times Cited: 107
Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds
Belgin Sever, Cüneyt Türkeş, Mehlika Dilek Altıntop, et al.
Archiv der Pharmazie (2021) Vol. 354, Iss. 12
Closed Access | Times Cited: 72
A decade of tail-approach based design of selective as well as potent tumor associated carbonic anhydrase inhibitors
Amit Kumar, Kiran Siwach, Claudiu T. Supuran, et al.
Bioorganic Chemistry (2022) Vol. 126, pp. 105920-105920
Closed Access | Times Cited: 55
Thiazole derivatives in medicinal chemistry: Recent advancements in synthetic strategies, structure activity relationship and pharmacological outcomes
Atamjit Singh, Danish Malhotra, Karanvir Singh, et al.
Journal of Molecular Structure (2022) Vol. 1266, pp. 133479-133479
Closed Access | Times Cited: 49
DeepDelta: predicting ADMET improvements of molecular derivatives with deep learning
Zachary Fralish, Ashley Chen, Paul Skaluba, et al.
Journal of Cheminformatics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Synthesis, structure elucidation, and in vitro pharmacological evaluation of novel polyfluoro substituted pyrazoline type sulfonamides as multi-target agents for inhibition of acetylcholinesterase and carbonic anhydrase I and II enzymes
Cem Yamalı, Halise İnci Gül, Cavit Kazaz, et al.
Bioorganic Chemistry (2020) Vol. 96, pp. 103627-103627
Closed Access | Times Cited: 65
Synthesis, cytotoxic evaluation, and molecular docking studies of novel quinazoline derivatives with benzenesulfonamide and anilide tails: Dual inhibitors of EGFR/HER2
Hamad M. Alkahtani, Ashraf N. Abdalla, Ahmad J. Obaidullah, et al.
Bioorganic Chemistry (2019) Vol. 95, pp. 103461-103461
Closed Access | Times Cited: 55
Remarkable utilization of quinazoline-based homosulfonamide for in vitro cytotoxic effects with triple kinase inhibition activities: cell cycle analysis and molecular docking profile
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Ahmed H. Bakheit, et al.
RSC Advances (2025) Vol. 15, Iss. 1, pp. 541-558
Open Access
Recent Advances in Biological Active Sulfonamide based Hybrid Compounds Part A: Two-Component Sulfonamide Hybrids
Reihane Ghomashi, Shakila Ghomashi, Hamidreza Aghaei, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 4, pp. 407-480
Closed Access | Times Cited: 20
Dependence on linkers’ flexibility designed for benzenesulfonamides targeting discovery of novel hCA IX inhibitors as potent anticancer agents
Haytham O. Tawfik, Amany Belal, Mohammed A. S. Abourehab, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2765-2785
Open Access | Times Cited: 19
Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation
Davide Moi, Alessio Nocentini, Alessandro Deplano, et al.
European Journal of Medicinal Chemistry (2019) Vol. 182, pp. 111638-111638
Open Access | Times Cited: 30
Pyrazole/pyrazoline as an excellent pharmacophore in the design of carbonic anhydrase inhibitors (2018–2022)
Atukuri Dorbabu
Archiv der Pharmazie (2023) Vol. 356, Iss. 4
Closed Access | Times Cited: 9
S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Silvia Bua, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2020) Vol. 35, Iss. 1, pp. 733-743
Open Access | Times Cited: 26
Chemistry of heterocycles as carbonic anhydrase inhibitors: A pathway to novel research in medicinal chemistry review
Anjaneyulu Bendi, Taruna, Rajni Rajni, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 7
Closed Access | Times Cited: 2
Design, synthesis, and carbonic anhydrase inhibition activities of Schiff bases incorporating benzenesulfonamide scaffold: Molecular docking application
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Silvia Bua, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 12, pp. 101866-101866
Open Access | Times Cited: 7
Synthesis and comparative carbonic anhydrase inhibition of new Schiff’s bases incorporating benzenesulfonamide, methanesulfonamide, and methylsulfonylbenzene scaffolds
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Silvia Bua, et al.
Bioorganic Chemistry (2019) Vol. 92, pp. 103225-103225
Closed Access | Times Cited: 21
Synthesis, anti-inflammatory, cytotoxic, and COX-1/2 inhibitory activities of cyclic imides bearing 3-benzenesulfonamide, oxime, and β-phenylalanine scaffolds: a molecular docking study
Alaa A.‐M. Abdel‐Aziz, Adel S. El‐Azab, Nawaf A. Alsaif, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2020) Vol. 35, Iss. 1, pp. 610-621
Open Access | Times Cited: 20
Exploring structure-activity relationship of S-substituted 2-mercaptoquinazolin-4(3H)-one including 4-ethylbenzenesulfonamides as human carbonic anhydrase inhibitors
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Hany E. A. Ahmed, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2020) Vol. 35, Iss. 1, pp. 598-609
Open Access | Times Cited: 18
Carbonic Anhydrase Inhibition Activities of Schiff’s Bases Based on Quinazoline-Linked Benzenesulfonamide
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Hazem A. Ghabbour, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 7703-7703
Open Access | Times Cited: 11
New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Silvia Bua, et al.
European Journal of Medicinal Chemistry (2019) Vol. 181, pp. 111573-111573
Closed Access | Times Cited: 15
Targeted Development of Pyrazoline Derivatives for Neurological Disorders: A Review
Anurag Chauhan, Salahuddin Salahuddin, Avijit Mazumder, et al.
ChemistrySelect (2024) Vol. 9, Iss. 16
Closed Access | Times Cited: 1
Synthesis, enzyme inhibition assay, and molecular modeling study of novel pyrazolines linked to 4-methylsulfonylphenyl scaffold: antitumor activity and cell cycle analysis
Alaa A.‐M. Abdel‐Aziz, Adel S. El‐Azab, Simone Brogi, et al.
RSC Advances (2024) Vol. 14, Iss. 31, pp. 22132-22146
Open Access | Times Cited: 1
Synthesis and aldose reductase inhibition effects of celecoxib derivatives containing pyrazole linked-sulfonamide moiety
Çetin Bayrak
Bioorganic Chemistry (2022) Vol. 128, pp. 106086-106086
Closed Access | Times Cited: 8
Synthesis, characterization and carbonic anhydrase I and II inhibitory evaluation of new sulfonamide derivatives bearing dithiocarbamate
Begüm Nurpelin Sağlık, Derya Osmani̇ye, Ulviye Acar Çevik, et al.
European Journal of Medicinal Chemistry (2020) Vol. 198, pp. 112392-112392
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top